Hammad Malik, MD
Interventional Pain Medicine · Richmond, KYNPI 1629063904
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $30,299 of the $34,694 with a category attached, or 87.3%. 30 manufacturers reported payments, led by Boston Scientific at 32.8% of the total. Among interventional pain medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 617 payments — averaging $56.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$11K
- Abbott$10K
- Medtronic$3K
- Biotronik NRO, Inc.$3K
- Nevro Corp.$2K
- Saluda Medical Americas, Inc.$2K
- plus $3K from 24 others
What the payments were for
- Travel & lodging$4,14612%
- Food & beverage$30,29987%
- Education$2501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 180 | $11,387 |
| Abbott | 168 | $10,095 |
| Medtronic(2 entities) | 43 | $3,173 |
| Biotronik NRO, Inc. | 73 | $3,032 |
| Nevro Corp. | 46 | $2,351 |
| Saluda Medical Americas, Inc. | 15 | $1,504 |
| Globus Medical | 19 | $1,087 |
| Vertos Medical, Inc. | 7 | $510 |
| Collegium Pharmaceutical, Inc. | 16 | $265 |
| Curonix LLC | 5 | $230 |
| Teva Pharmaceuticals USA, Inc. | 4 | $182 |
| Stryker | 1 | $172 |
| Amgen(2 entities) | 8 | $104 |
| Painteq LLC | 1 | $74 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $73 |
| Pfizer | 6 | $71 |
| Foundation Fusion Solutions, LLC | 2 | $66 |
| Scilex Pharmaceuticals Inc. | 3 | $52 |
| Azurity Pharmaceuticals, Inc. | 3 | $46 |
| AbbVie | 2 | $45 |
| Biodelivery Sciences International, Inc. | 2 | $28 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| MDD US Operations, LLC | 1 | $21 |
| GRT US Holding, Inc. | 1 | $19 |
| Convatec Inc. | 1 | $17 |
| Forte Bio-pharma LLC | 1 | $16 |
| Si-bone, Inc. | 1 | $14 |
| Spinal Simplicity, LLC | 1 | $14 |
| Flowonix Medical Incorporated | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$3,184
- PROCLAIM$2,986
- GENERAL PAIN MANAGEMENT$1,878
- SPECTRA WAVEWRITER$1,606
- Prospera$1,203
- Evoke$1,031
- KYPHON Balloon Kyphoplasty$963
- INTELLIS$902
- Senza$851
- WaveWriter Alpha Prime 16$832
- Proclaim IPG$722
- Neuromodulation Dspsbls and Accs$632
- Omnia$617
- mild Device Kit$594
- Senza Spinal Cord Stimulation System$401
- BIOTRONIK$375
- Superion Indirect Decompression System$254
- INTELLIS ADAPTIVESTIM$243
- Vyrsa V1$208
- ETERNA$166
How this compares
$34,694 in reported general payments places this provider in the 95th percentile of 55 interventional pain medicine providers in Kentucky.
See all interventional pain medicine providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 67 | $50,505 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,393 | $37,669 |
| Buprenorphine | 135 | $36,267 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,563 | $31,068 |
| Xtampza ErOxycodone Myristate | 44 | $22,406 |
| MovantikNaloxegol Oxalate | 29 | $13,396 |
| Fentanyl | 107 | $9,854 |
| OxycontinOxycodone Hcl | 17 | $8,601 |
| LinzessLinaclotide | 14 | $8,403 |
| Oxycodone Hcl | 456 | $7,770 |
| Gabapentin | 524 | $6,724 |
| Morphine Sulfate ErMorphine Sulfate | 157 | $4,270 |
| Pregabalin | 183 | $2,892 |
| Lubiprostone | 14 | $2,699 |
| Methadone Hcl | 97 | $1,756 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $265 | $72,911111 claims |
| AbbVieLinzess | $45 | $8,40314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 55 interventional pain medicine providers in Kentucky.
Other interventional pain medicine in Richmond
- Robert KlickovichFlorence$57K
- Michael FletcherFlorence$18K
- Vishal BansalMadisonville$13K
- Anand ModaduguLexington$12K
- Zachary KlingerCorbin$10K
- Nathan LambornLouisville$10K
- Brock MarrsLexington$9K
- Brandon SuttonLouisville$9K
- Gary ReasorLouisville$9K
- Sai GuttiPikeville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.